St. Louis, Missouri

Biomedical Systems’ corporate campus is located in St. Louis, Missouri. With three buildings housing over 300 employees, St. Louis is the hub of strategic planning and execution for the Clinical Trial, Physician/Hospital Services, and Medical Products divisions of Biomedical Systems.

Brussels, Belgium

Biomedical Systems’ European headquarters is located in the heart of Europe – Brussels, Belgium. In addition to being the capital of Belgium, Brussels is also the administrative centre of the European Union and is a centrally located to all the major drug development areas in Western Europe. The Brussels office, which now employs over 100 people, celebrated its 30th year of operations in 2011. For more information on our European operations contact  us at  This e-mail address is being protected from spambots. You need JavaScript enabled to view it. .

Tsukuba, Japan

In 2008, Biomedical Systems opened a logistics and support facility in the city of Tsukuba about 50 km northeast of Tokyo and home to a burgeoning life sciences community. The Tsukuba office provides logistical support for equipment, operations, and training for pharmaceutical studies located in Asia, particularly for Japanese based clinical trial sites.

Mr. Marcio Shiratsuchi oversees Tsukuba operations and contributes a rich background in the technical aspects of clinical trial work in addition to being fluent in four languages. Currently, project management for centralized data acquired and analyzed continues to be handled from our North American and European headquarters; however, Biomedical Systems’ goal is to provide our clients with support as close to their corporate operations as possible. We understand the crucial need to employ those familiar with the languages and customs of regions in which Biomedical Systems operates to facilitate the clinical process.

Pondicherry, India

A growing number of clinical sites in the subcontinent propelled Biomedical Systems’ decision to expand into India in 2009. Fully operational in the spring of 2010, this office provides logistics and technical support to regional investigative sites. A stock of equipment and disposables is maintained at Biomedical Systems’ Indian office, allowing the expedited distribution of equipment and supplies and providing continuity in the day-to-day management of clinical trials.

India's pharmaceutical market is the second largest in Asia, with a more than 9% annual growth. The number of clinical trials in India sponsored by domestic and global pharmaceutical companies has risen sharply over the last few years. The industry’s attraction to India can be explained by the abundance of life sciences professionals experienced in Good Clinical Practice, a wide network of hospitals and healthcare institutions, as well as an adequate infrastructure and competitive costs advantages. Furthermore, rapidly advancing capabilities in project and data management are making India a location of choice for pharmaceutical research and development.